GB2415696A - Process for preparing almodipline mesylate monohydrate - Google Patents

Process for preparing almodipline mesylate monohydrate Download PDF

Info

Publication number
GB2415696A
GB2415696A GB0522075A GB0522075A GB2415696A GB 2415696 A GB2415696 A GB 2415696A GB 0522075 A GB0522075 A GB 0522075A GB 0522075 A GB0522075 A GB 0522075A GB 2415696 A GB2415696 A GB 2415696A
Authority
GB
United Kingdom
Prior art keywords
almodipline
preparing
mesylate monohydrate
mesylate
amlodipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0522075A
Other versions
GB0522075D0 (en
GB2415696B (en
Inventor
Rajendra Narayanrao Kankan
Dharmaraj Ramachandra Rao
Pathi L Srinivas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0309471A external-priority patent/GB0309471D0/en
Priority claimed from GB0314617A external-priority patent/GB0314617D0/en
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of GB0522075D0 publication Critical patent/GB0522075D0/en
Publication of GB2415696A publication Critical patent/GB2415696A/en
Application granted granted Critical
Publication of GB2415696B publication Critical patent/GB2415696B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Amlodipine mesylate monohydrate is prepared either from anhydrous amlodipine mesylate, or in the presence of a water immiscible solvent medium from amlodipine free base and methane sulphonic acid.

Description

GB 2415696 A continuation (72) Inventor(s): Rajendra Narayanrao Kankan
Dharmaraj Ramachandra Rao Pathi L Srinivas (74) Agent and/or Address for Service: A A Thornton & Co 235 High Holborn, LONDON, WC1V 7LE, United Kingdom
GB0522075A 2003-04-25 2004-04-16 Process for preparing amlodipine mesylate monohydrate Expired - Fee Related GB2415696B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0309471A GB0309471D0 (en) 2003-04-25 2003-04-25 Process
GB0314617A GB0314617D0 (en) 2003-06-23 2003-06-23 Process
PCT/GB2004/001638 WO2004096770A1 (en) 2003-04-25 2004-04-16 Process for preparing almodipine mesylate monohydrate

Publications (3)

Publication Number Publication Date
GB0522075D0 GB0522075D0 (en) 2005-12-07
GB2415696A true GB2415696A (en) 2006-01-04
GB2415696B GB2415696B (en) 2007-06-20

Family

ID=33420880

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0522075A Expired - Fee Related GB2415696B (en) 2003-04-25 2004-04-16 Process for preparing amlodipine mesylate monohydrate

Country Status (6)

Country Link
AR (1) AR044063A1 (en)
CL (1) CL2004000864A1 (en)
DE (1) DE112004000712T5 (en)
GB (1) GB2415696B (en)
PA (1) PA8601501A1 (en)
WO (1) WO2004096770A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1152013C (en) * 2001-11-22 2004-06-02 张喜田 Levo-amlodipine salt able to generate hydrate and its hydrate and preparation
CN112538044B (en) * 2019-12-09 2021-08-13 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, and preparation method and application thereof
WO2021114012A1 (en) * 2019-12-09 2021-06-17 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, preparation method therefor and use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089167A2 (en) * 1982-03-11 1983-09-21 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents, processes for their production, and pharmaceutical compositions containing them
EP0244944A2 (en) * 1986-04-04 1987-11-11 Pfizer Limited Salts of amlodipine
EP1221438A2 (en) * 2001-01-09 2002-07-10 Siegfried Ltd. Amlodipine mesylate salts

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089167A2 (en) * 1982-03-11 1983-09-21 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents, processes for their production, and pharmaceutical compositions containing them
EP0244944A2 (en) * 1986-04-04 1987-11-11 Pfizer Limited Salts of amlodipine
EP1221438A2 (en) * 2001-01-09 2002-07-10 Siegfried Ltd. Amlodipine mesylate salts

Also Published As

Publication number Publication date
AR044063A1 (en) 2005-08-24
GB0522075D0 (en) 2005-12-07
WO2004096770A1 (en) 2004-11-11
CL2004000864A1 (en) 2005-04-22
GB2415696B (en) 2007-06-20
PA8601501A1 (en) 2004-12-16
DE112004000712T5 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
GB2396311A (en) Controlled release of additives in cooling system
GB2399851A (en) Acid soluble, high fluid loss pill for lost circulation
GB2404060A (en) Filtering contents using a learning mechanism
GB2384502A (en) Radial expansion of tubular members
GB2409650A (en) Method and apparatus for remote game device with failure fallback and restoration
GB2394431A (en) Controlled release of additives in fluid systems
GB2394979A (en) Liner hanger
GB2395506A (en) Liner hanger
GB2395877A (en) Selecting a security format conversion for wired and wireless devices
GB2397601A (en) Method and apparatus for expanding and separating tubulars in a wellbore
GB2411498A (en) Decoupled hardware configuration manager
GB2394975A (en) Tubing expansion
GB2415988A (en) Apparatus for radially expanding and plastically deforming a tubular member
GB2429206A (en) Process for the synthesis of hydromorphone
GB2426248A (en) Anion-binding polymers and uses thereof
GB2407604A (en) Multilateral injection /production/storage completion method
GB2416361A (en) Apparatus and method for running a radially expandable tubular member
GB2395738A (en) Method and apparatus for coiled tubing operations
GB2416794A (en) Apparatus for radially expanding and plastically deforming a tubular member
GB2415454A (en) Apparatus for radially expanding and plastically deforming a tubular member
GB2415987A (en) Apparatus for radially expanding and plastically deforming a tubular member
GB2410519A (en) Apparatus and methods for installing casing in a borehole
GB2416795A (en) Apparatus for radially expanding and plastically deforming a tubular member
GB2415696A (en) Process for preparing almodipline mesylate monohydrate
GB2429602A (en) Configuration of redirection tables

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130416